These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21095328)

  • 21. eComment: Mechanical valve replacement in the elderly: does anticoagulation have benefit?
    Gunay R
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):581-2. PubMed ID: 19773234
    [No Abstract]   [Full Text] [Related]  

  • 22. Aortic valve replacement dilemma: mechanical or biological prosthesis?
    Cannata A; Russo CF; Taglieri C
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1101-2; author reply 1102. PubMed ID: 18954665
    [No Abstract]   [Full Text] [Related]  

  • 23. The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements.
    O'Brien MF; Harrocks S; Stafford EG; Gardner MA; Pohlner PG; Tesar PJ; Stephens F
    J Heart Valve Dis; 2001 May; 10(3):334-44; discussion 335. PubMed ID: 11380096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement.
    Sjögren J; Gudbjartsson T; Thulin LI
    J Heart Valve Dis; 2006 Mar; 15(2):197-202. PubMed ID: 16607900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prosthetic valve endocarditis with ring abscesses. Surgical management and long-term results.
    Jault F; Gandjbakhch I; Chastre JC; Levasseur JP; Bors V; Gibert C; Pavie A; Cabrol C
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1106-13. PubMed ID: 8501938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
    McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
    Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement using a St. Jude Medical prosthesis.
    Emery RW; Krogh CC; McAdams S; Emery AM; Holter AR
    J Heart Valve Dis; 2010 Jul; 19(4):473-84. PubMed ID: 20845896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of patient-prosthesis mismatch on long-term results after aortic valve replacement with a stented bioprosthesis.
    Frapier JM; Rouvière P; Razcka F; Aymard T; Albat B; Chaptal PA
    J Heart Valve Dis; 2002 Jul; 11(4):543-51. PubMed ID: 12150304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prosthesis-patient mismatch on long-term survival with aortic valve replacement: assessment to 15 years.
    Jamieson WR; Ye J; Higgins J; Cheung A; Fradet GJ; Skarsgard P; Germann E; Chan F; Lichtenstein SV
    Ann Thorac Surg; 2010 Jan; 89(1):51-8; discussion 59. PubMed ID: 20103205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results and determinants of mortality after surgery for native and prosthetic valve endocarditis.
    Grünenfelder J; Akins CW; Hilgenberg AD; Vlahakes GJ; Torchiana DF; Madsen JC; MacGillivray TE
    J Heart Valve Dis; 2001 Nov; 10(6):694-702. PubMed ID: 11767173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of survival after aortic valve replacement as treatment for symptomatic aortic valve disease in the elderly.
    Mistiaen WP; Van Cauwelaert P; Muylaert P; Van Hove M; Sys SU; Harrisson F; Bunarto J; Delaruelle J; Bortier H
    J Heart Valve Dis; 2001 May; 10(3):354-60. PubMed ID: 11380098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of valve-related complications in patients with Sorin Bicarbon prosthesis: a seven-year experience.
    Bortolotti U; Milano A; D'Alfonso A; Piccin C; Mecozzi G; Magagna P; Fabbri A; Mazzucco A
    J Heart Valve Dis; 2001 Nov; 10(6):795-801. PubMed ID: 11767189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
    Mykén PS
    J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The stentless freestyle bioprosthesis: impact of age over 80 years on quality of life, perioperative, and mid-term outcome.
    Ennker J; Dalladaku F; Rosendahl U; Ennker IC; Mauser M; Florath I
    J Card Surg; 2006; 21(4):379-85. PubMed ID: 16846417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decision-making in the choice of heart valve for replacement in patients aged 60-70 years: twenty-year follow up of the St. Jude Medical aortic valve prosthesis.
    Emery RW; Arom KV; Kshettry VR; Kroshus TJ; Von R; Kersten TE; Lillehei TJ; Nicoloff DM; Erickson CA
    J Heart Valve Dis; 2002 Jan; 11 Suppl 1():S37-44. PubMed ID: 11843519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aortic valve replacement: technique and outcome with artificial heart valves and allografts].
    Vogt PR; Turina MI
    Ther Umsch; 1998 Dec; 55(12):737-45. PubMed ID: 10025187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis.
    Muehrcke DD; Lytle BW; Cosgrove DM
    Ann Thorac Surg; 1995 Sep; 60(3):538-43. PubMed ID: 7677477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
    D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invited commentary. It would not be wise to completely abandon the use of homograft root replacement in particular in patients with prosthetic valve endocarditis and aortic root abscess.
    Mihaljevic T
    Ann Thorac Surg; 2007 Dec; 84(6):1942. PubMed ID: 18036911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.